Although there are also a few studies have been conducted to investigate the prognostic value of NLR in melanoma patients treated with anti-PD-1 antibodies, these studies evaluated the caucasian population, and there are no data from Chinese melanoma patients. The gene discussed is PDCD1; the disease is melanoma.